Rifampicin and rifabutin resistance in 1003 Mycobacterium tuberculosis clinical isolates
出版年份 2019 全文链接
标题
Rifampicin and rifabutin resistance in 1003 Mycobacterium tuberculosis clinical isolates
作者
关键词
-
出版物
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2019-01-31
DOI
10.1093/jac/dkz048
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Validating a 14-drug microtitre plate containing bedaquiline and delamanid for large-scale research susceptibility testing of Mycobacterium tuberculosis
- (2018) Paola M. V. Rancoita et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Protective effects of household-based TB interventions are robust to neighbourhood-level variation in exposure risk in Lima, Peru: a model-based analysis
- (2017) Jon Zelner et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Treatment outcomes of rifabutin-containing regimens for rifabutin-sensitive multidrug-resistant pulmonary tuberculosis
- (2017) Hyun Lee et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing
- (2017) Soumitesh Chakravorty et al. mBio
- Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study
- (2017) Keertan Dheda et al. Lancet Respiratory Medicine
- Genetic Determinants of Drug Resistance inMycobacterium tuberculosisand Their Diagnostic Value
- (2016) Maha R. Farhat et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
- (2016) Payam Nahid et al. CLINICAL INFECTIOUS DISEASES
- Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex
- (2016) Zenda L. Berrada et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Gyrase Mutations Are Associated with Variable Levels of Fluoroquinolone Resistance in Mycobacterium tuberculosis
- (2016) Maha R. Farhat et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study
- (2015) Timothy M Walker et al. LANCET INFECTIOUS DISEASES
- Detection of Drug-Resistant Tuberculosis by Xpert MTB/RIF in Swaziland
- (2015) Elisabeth Sanchez-Padilla et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis
- (2015) Phelim Bradley et al. Nature Communications
- TGS-TB: Total Genotyping Solution for Mycobacterium tuberculosis Using Short-Read Whole-Genome Sequencing
- (2015) Tsuyoshi Sekizuka et al. PLoS One
- Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
- (2014) Abdullah Alsultan et al. DRUGS
- Profiling of rpoB Mutations and MICs for Rifampin and Rifabutin in Mycobacterium tuberculosis
- (2014) F. B. Jamieson et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications
- (2014) Andy Rimmer et al. NATURE GENETICS
- A robust SNP barcode for typing Mycobacterium tuberculosis complex strains
- (2014) Francesc Coll et al. Nature Communications
- Kraken: ultrafast metagenomic sequence classification using exact alignments
- (2014) Derrick E Wood et al. GENOME BIOLOGY
- Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy
- (2014) Suhashni Naiker et al. BMC Pharmacology & Toxicology
- Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis
- (2013) H. Nebenzahl-Guimaraes et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis
- (2013) Maha R Farhat et al. NATURE GENETICS
- Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-β-D-arabinose biosynthetic and utilization pathway genes
- (2013) Hassan Safi et al. NATURE GENETICS
- The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks
- (2013) Frederick A. Sirgel et al. PLoS One
- The efficacy of rifabutin for rifabutin-susceptible, multidrug-resistant tuberculosis
- (2012) Kyung-Wook Jo et al. RESPIRATORY MEDICINE
- MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods
- (2011) K. Tamura et al. MOLECULAR BIOLOGY AND EVOLUTION
- Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection
- (2011) Christopher B Ford et al. NATURE GENETICS
- Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro
- (2011) Sumandeep K. Gill et al. TUBERCULOSIS
- Stampy: A statistical algorithm for sensitive and fast mapping of Illumina sequence reads
- (2010) G. Lunter et al. GENOME RESEARCH
- The Sequence Alignment/Map format and SAMtools
- (2009) H. Li et al. BIOINFORMATICS
- Pharmacokinetic Evaluation of Rifabutin in Combination with Lopinavir‐Ritonavir in Patients with HIV Infection and Active Tuberculosis
- (2009) Catherine Boulanger et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started